1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. VETERINARY VACCINE MARKET BY VACCINE TYPE
5.1. Introduction
5.2. Live Attenuated Vaccine
5.3. Inactive/Killed Vaccine
5.4. Toxoid Vaccine
5.5. Subunit & Conjugate Vaccine
5.6. Others
6. VETERINARY VACCINE MARKET BY MODE OF ADMINISTRATION
6.1. Introduction
6.2. Oral
6.3. Parental
6.4. Others
7. VETERINARY VACCINE MARKET BY ANIMAL TYPE
7.1. Introduction
7.2. Companion Animals
7.3. Livestock Animals
7.3.1. Cattle
7.3.2. Poultry
7.3.3. Swine
7.3.4. Others
8. VETERINARY VACCINE MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Vaccine Type
8.2.2. By Mode of Administration
8.2.3. By Animal Type
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Vaccine Type
8.3.2. By Mode of Administration
8.3.3. By Animal Type
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Vaccine Type
8.4.2. By Mode of Administration
8.4.3. By Animal Type
8.4.4. By Country
8.4.4.1. Germany
8.4.4.2. France
8.4.4.3. United Kingdom
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Vaccine Type
8.5.2. By Mode of Administration
8.5.3. By Animal Type
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Israel
8.5.4.4. Others
8.6. Asia Pacific
8.6.1. By Vaccine Type
8.6.2. By Mode of Administration
8.6.3. By Animal Type
8.6.4. By Country
8.6.4.1. China
8.6.4.2. India
8.6.4.3. Japan
8.6.4.4. South Korea
8.6.4.5. Indonesia
8.6.4.6. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Elanco
10.2. Zoetis Inc.
10.3. Ceva
10.4. Merck Animal Health
10.5. Phibro Animal Health Corporation
10.6. Virbac
10.7. Hester Bioscience Limited
10.8. Hipra
10.9. Boehringer Ingelheim International GmbH
10.10. AdvaCare Pharma
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES